News
TORONTO, June 11, 2025 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (LABS:CA) (OTCQB: MEDIF) (FSE: MLZ) (“MediPharm,” the “Company,” “we” or “us”), a ...
ECAT offers a compelling 22.84% yield and trades at a 4.37% discount to NAV. Click to learn about the proxy vote, Saba's impact, and why ECAT is a hold.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback